Chemistry, Manufacturing Controls (CMC) in an Investigational New Drug (IND) (7/14) REdI 2017
54:28
Overview of Non-clinical Assessment in Drug Development (8/14) REdI 2017
28:11
Post-approval Considerations for Changes to Manufacturing Process and Facilities - REdI 2020
33:18
Investigational New Drug (IND) Submission: Content/Format and First 30 Days (5of14) REdI 2018
5:01
Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic aci...
29:42
CMC Considerations for CAR T Cell Product Development
24:20
Overview of the Quality System Regulation
20:43
VIRTUAL PRESS CONFERENCE: FDA’s Proposed Rule on Reducing Nicotine Levels – 1/15/2025
17:02